Cargando…
Necrosis targeted radiotherapy with iodine-131-labeled hypericin to improve anticancer efficacy of vascular disrupting treatment in rabbit VX2 tumor models
A viable rim of tumor cells surrounding central necrosis always exists and leads to tumor recurrence after vascular disrupting treatment (VDT). A novel necrosis targeted radiotherapy (NTRT) using iodine-131-labeled hypericin ((131)I-Hyp) was specifically designed to treat viable tumor rim and improv...
Autores principales: | Shao, Haibo, Zhang, Jian, Sun, Ziping, Chen, Feng, Dai, Xu, Li, Yaming, Ni, Yicheng, Xu, Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546464/ https://www.ncbi.nlm.nih.gov/pubmed/26036625 |
Ejemplares similares
-
Evaluation of the Therapeutic Efficacy of Sequential Therapy Involving Percutaneous Microwave Ablation in Combination with (131)I-Hypericin Using the VX2 Rabbit Breast Solid Tumor Model
por: Zhu, Miao, et al.
Publicado: (2015) -
Improved therapeutic outcomes of thermal ablation on rat orthotopic liver allograft sarcoma models by radioiodinated hypericin induced necrosis targeted radiotherapy
por: Gao, Long, et al.
Publicado: (2016) -
Necrosis Avidity: A Newly Discovered Feature of Hypericin and its Preclinical Applications in Necrosis Imaging
por: Jiang, Binghu, et al.
Publicado: (2013) -
Exploring Theranostic Potentials of Radioiodinated Hypericin in Rodent Necrosis Models
por: Li, Junjie, et al.
Publicado: (2012) -
Pictorial Imaging-Histopathology Correlation in a Rabbit with Hepatic VX2 Tumor Treated by Transarterial Vascular Disrupting Agent Administration
por: He, Jintong, et al.
Publicado: (2020)